These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 4649287)
1. [Pancreatic enzymes--substitution preparations]. Berndt W Z Allgemeinmed; 1972 Dec; 48(35):1641-4. PubMed ID: 4649287 [No Abstract] [Full Text] [Related]
2. [In vitro studies of pancreatic enzyme substitution]. Otte M; Ridder P; Dageförde J Dtsch Med Wochenschr; 1987 Sep; 112(39):1498-502. PubMed ID: 2443331 [TBL] [Abstract][Full Text] [Related]
3. [Enzymatic activity of drugs used for pancreatic substitution therapy--analysis in vitro]. Malis F; Fric P Cesk Gastroenterol Vyz; 1973 Mar; 27(2):89-97. PubMed ID: 4688457 [No Abstract] [Full Text] [Related]
4. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis]. Zsíros J; Sólyom E Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773 [No Abstract] [Full Text] [Related]
5. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Dutta SK; Rubin J; Harvey J Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746 [TBL] [Abstract][Full Text] [Related]
7. Intestinal concentrations of pancreatic enzymes following pancreatic replacement therapy. Ihse I; Lilja P; Lundquist I Scand J Gastroenterol; 1980; 15(2):137-44. PubMed ID: 6155686 [TBL] [Abstract][Full Text] [Related]
8. [Substitution therapy with pancreatic enzymes]. Tillander H Lakartidningen; 1971 Feb; 68(8):825-32. PubMed ID: 5546731 [No Abstract] [Full Text] [Related]
9. Controversies in the treatment of exocrine pancreatic insufficiency. DiMagno EP Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479 [No Abstract] [Full Text] [Related]
10. [In-vitro analysis of substances used in pancreozymin substitution therapy]. Malis F; Fric P Arzneimittelforschung; 1974 Apr; 24(4):499-504. PubMed ID: 4408063 [No Abstract] [Full Text] [Related]
11. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts. Graham DY N Engl J Med; 1977 Jun; 296(23):1314-7. PubMed ID: 16212 [TBL] [Abstract][Full Text] [Related]
12. Assessment of adequacy of pancreatic enzyme replacement with the multiple-phase carbon-14-triolein test. O'Keefe SJ; Adam J S Afr Med J; 1984 Nov; 66(20):763-5. PubMed ID: 6208620 [TBL] [Abstract][Full Text] [Related]
13. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy]. Löser C; Fölsch UR Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011 [TBL] [Abstract][Full Text] [Related]
14. Medical treatment of pancreatic insufficiency. DiMagno EP Mayo Clin Proc; 1979 Jul; 54(7):435-42. PubMed ID: 36518 [TBL] [Abstract][Full Text] [Related]